{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:13:31Z","timestamp":1777565611169,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00198-013-2420-8","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T09:53:57Z","timestamp":1372326837000},"page":"77-83","source":"Crossref","is-referenced-by-count":30,"title":["Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial"],"prefix":"10.1007","volume":"25","author":[{"given":"D.","family":"Prieto-Alhambra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. K.","family":"Arden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. W.","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"issue":"1\u20132","key":"2420_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","volume":"6","author":"O Str\u00f6m","year":"2011","unstructured":"Str\u00f6m O, Borgstr\u00f6m F, Kanis J, Compston J, Cooper C, McCloskey E, J\u00f6nsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6(1\u20132):59\u2013155","journal-title":"Arch Osteoporos"},{"key":"2420_CR2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00198-011-1642-x","volume":"22","author":"D Marsh","year":"2011","unstructured":"Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051\u20132065","journal-title":"Osteoporos Int"},{"key":"2420_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/gerona\/glp003","volume":"64","author":"BD Lloyd","year":"2009","unstructured":"Lloyd BD, Williamson DA, Singh NA, Hansen RD, Diamond TH, Finnegan TP, Allen BJ, Grady JN, Stavrinos TM, Smith EU, Diwan AD, Fiatarone Singh MA (2009) Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. J Gerontol A Biol Sci Med Sci 64:599\u2013609","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2420_CR4","first-page":"200","volume":"75","author":"TR Beringer","year":"2006","unstructured":"Beringer TR, Clarke J, Elliott JR, Marsh DR, Heyburn G, Steele IC (2006) Outcome following proximal femoral fracture in Northern Ireland. Ulster Med J 75:200\u2013206","journal-title":"Ulster Med J"},{"key":"2420_CR5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jamda.2009.12.004","volume":"11","author":"JR Curtis","year":"2010","unstructured":"Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E (2010) Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc 11:584\u2013591","journal-title":"J Am Med Dir Assoc"},{"key":"2420_CR6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"2420_CR7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/gerona\/62.8.872","volume":"62","author":"SA Vik","year":"2007","unstructured":"Vik SA, Jantzi M, Poss J, Hirdes J, Hanley DA, Hogan DB, Maxwell CJ (2007) Factors associated with pharmacologic treatment of osteoporosis in an older home care population. J Gerontol A Biol Sci Med Sci 62:872\u2013878","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2420_CR8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00198-011-1636-8","volume":"23","author":"Y Haasum","year":"2012","unstructured":"Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061\u20131068","journal-title":"Osteoporos Int"},{"key":"2420_CR9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"2420_CR10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","volume":"23","author":"E Pfeiffer","year":"1975","unstructured":"Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23:433\u2013441","journal-title":"J Am Geriatr Soc"},{"key":"2420_CR11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1532-5415.1987.tb04662.x","volume":"35","author":"T Erkinjuntti","year":"1987","unstructured":"Erkinjuntti T, Sulkava R, Wikstrom J, Autio L (1987) Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc 35:412\u2013416","journal-title":"J Am Geriatr Soc"},{"key":"2420_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","volume":"58","author":"SD Berry","year":"2010","unstructured":"Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58:783\u2013787","journal-title":"J Am Geriatr Soc"},{"key":"2420_CR13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistributions of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"2420_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219","journal-title":"BMJ"},{"key":"2420_CR15","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","volume":"340","author":"X Sun","year":"2010","unstructured":"Sun X, Briel M, Walter SD, Guyatt GH (2010) Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 340:c117","journal-title":"BMJ"},{"key":"2420_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00198-012-2051-5","volume":"24","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Lix LM, Wu X (2012) Competing mortality and fracture risk assessment. Osteoporos Int 24:681\u2013688","journal-title":"Osteoporos Int"},{"key":"2420_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jama.2009.2024","volume":"303","author":"ME Tinetti","year":"2010","unstructured":"Tinetti ME, Kumar C (2010) The patient who falls: \u201cIt\u2019s always a trade-off\u201d. JAMA 303:258\u2013266","journal-title":"JAMA"},{"key":"2420_CR18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","volume":"58","author":"BJ Gertz","year":"1995","unstructured":"Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG (1995) Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 58:288\u2013298","journal-title":"Clin Pharmacol Ther"},{"key":"2420_CR19","doi-asserted-by":"crossref","first-page":"M187","DOI":"10.1093\/geronj\/48.5.M187","volume":"48","author":"MD Ensberg","year":"1993","unstructured":"Ensberg MD, Paletta MJ, Galecki AT, Dacko CL, Fries BE (1993) Identifying elderly patients for early discharge after hospitalization for hip fracture. J Gerontol 48:M187\u2013195","journal-title":"J Gerontol"},{"key":"2420_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0003-9993(99)90281-2","volume":"80","author":"RJ Heruti","year":"1999","unstructured":"Heruti RJ, Lusky A, Barell V, Ohry A, Adunsky A (1999) Cognitive status at admission: does it affect the rehabilitation outcome of elderly patients with hip fracture? Arch Phys Med Rehabil 80:432\u2013436","journal-title":"Arch Phys Med Rehabil"},{"key":"2420_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00002060-200110000-00006","volume":"80","author":"M Cree","year":"2001","unstructured":"Cree M, Carriere KC, Soskolne CL, Suarez-Almazor M (2001) Functional dependence after hip fracture. Am J Phys Med Rehabil 80:736\u2013743","journal-title":"Am J Phys Med Rehabil"},{"key":"2420_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.apmr.2009.09.018","volume":"91","author":"J Hirose","year":"2010","unstructured":"Hirose J, Ide J, Yakushiji T, Abe Y, Nishida K, Maeda S, Anraku Y, Usuku K, Mizuta H (2010) Prediction of postoperative ambulatory status 1\u00a0year after hip fracture surgery. Arch Phys Med Rehabil 91:67\u201372","journal-title":"Arch Phys Med Rehabil"},{"key":"2420_CR23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1302\/0301-620X.63B4.7298685","volume":"63B","author":"L Ceder","year":"1981","unstructured":"Ceder L, Elmqvist D, Svensson SE (1981) Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. J Bone Joint Surg Br 63B:560\u2013566","journal-title":"J Bone Joint Surg Br"},{"key":"2420_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1302\/0301-620X.74B2.1544951","volume":"74","author":"DJ Wood","year":"1992","unstructured":"Wood DJ, Ions GK, Quinby JM, Gale DW, Stevens J (1992) Factors which influence mortality after subcapital hip fracture. J Bone Joint Surg Br 74:199\u2013202","journal-title":"J Bone Joint Surg Br"},{"key":"2420_CR25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ageing\/8.4.246","volume":"8","author":"JG Evans","year":"1979","unstructured":"Evans JG, Prudham D, Wandless I (1979) A prospective study of fractured proximal femur: factors predisposing to survival. Age Ageing 8:246\u2013250","journal-title":"Age Ageing"},{"key":"2420_CR26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/aen236","volume":"101","author":"MJ Maxwell","year":"2008","unstructured":"Maxwell MJ, Moran CG, Moppett IK (2008) Development and validation of a preoperative scoring system to predict 30\u00a0day mortality in patients undergoing hip fracture surgery. Br J Anaesth 101:511\u2013517","journal-title":"Br J Anaesth"},{"issue":"4","key":"2420_CR27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/bja\/aeq405","volume":"106","author":"MD Wiles","year":"2011","unstructured":"Wiles MD, Moran CG, Sahota O, Moppett IK (2011) Nottingham Hip Fracture Score as a predictor of one year mortality in patients undergoing surgical repair of fractured neck of femur. Br J Anaesth 106(4):501\u2013504","journal-title":"Br J Anaesth"},{"key":"2420_CR28","unstructured":"Currie C, Partridge M, Plant F, Roberts J, Wakeman R, Williams A (2011) The National Hip Fracture Database National Report 2011. In Partnership HQI (ed)."},{"key":"2420_CR29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinte.165.15.1737","volume":"165","author":"Y Sato","year":"2005","unstructured":"Sato Y, Kanoko T, Satoh K, Iwamoto J (2005) The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 165:1737\u20131742","journal-title":"Arch Intern Med"},{"key":"2420_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archinte.167.5.513-b","volume":"167","author":"JM Halbekath","year":"2007","unstructured":"Halbekath JM, Schenk S, von Maxen A, Meyer G, Muhlhauser I (2007) Risedronate for the prevention of hip fractures: concern about validity of trials. Arch Intern Med 167:513\u2013514, author reply 514\u2013515","journal-title":"Arch Intern Med"},{"key":"2420_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1359\/jbmr.090704","volume":"25","author":"CS Colon-Emeric","year":"2010","unstructured":"Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P, Eriksen EF, Magaziner J (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25:91\u201397","journal-title":"J Bone Miner Res"},{"key":"2420_CR32","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1136\/bmj.e1553","volume":"344","author":"X Sun","year":"2012","unstructured":"Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D, Diaz-Granados N, Vandvik PO, Malaga G, Srinathan SK, Dahm P, Johnston BC, Alonso-Coello P, Hassouneh B, Walter SD, Heels-Ansdell D, Bhatnagar N, Altman DG, Guyatt GH (2012) Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 344:e1553","journal-title":"BMJ"},{"key":"2420_CR33","doi-asserted-by":"crossref","first-page":"e2022","DOI":"10.1136\/bmj.e2022","volume":"344","author":"AD Oxman","year":"2012","unstructured":"Oxman AD (2012) Subgroup analyses. BMJ 344:e2022","journal-title":"BMJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2420-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2420-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T13:24:15Z","timestamp":1563283455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2420-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2420"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2420-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}